You are so right, McMagyar, and the enemy has already an answer for the Melbourne results.
I passed on the article and the video to the director of a local senior day care center where early to mild Alzheimer's patient attend. She, in turn, sent it to a local doctor who I believe is working with Biogen and its drug, aducanumab.
Instead of replying that news is great or have heard about the results, he responded, "... there are many drugs in small trials currently, and a few in larger trials. This piece is sensational journalism ..." [My emphasis]
BP will not never quit demonizing Anavex until it is bought out (and buried) or receives FDA approval, becomes SOC and is endorsed by the AMA, whose doctors fear revenue losses if Anavex succeeds.